What is Injective (INJ)? A gateway to decentralized finance

Dubbed "the blockchain built for finance," Injective is an interoperable and environmentally friendly layer-1 network empowering developers to build powerful decentralized finance (DeFi) applications seamlessly. Its purpose? To revolutionize access to financial markets and eliminate barriers to entry.

In this guide, we'll walk you through Injective's utility, functionalities, tokenomics, and its role in the broader DeFi ecosystem.

What is Injective (INJ)?

Many would argue that Injective isn't your average blockchain — it's a layer-1 protocol carefully designed to serve the intricate needs of the financial world. Injective is an interoperable and eco-friendly blockchain, strategically positioned as a versatile canvas for developers to paint the future of DeFi applications. Whether you're envisioning crypto trading, decentralized applications (DApps), spot and derivative crypto exchanges, or lending protocols, Injective provides the fundamental infrastructure for developers to turn their ideas into reality.

At the heart of this financial revolution is the native utility token, INJ. The token steers protocol governance, fuels developer incentives, and enhances network security through a Tendermint-based proof-of-stake (PoS) consensus mechanism.

How does Injective work?

Injective functions as a public blockchain, welcoming all interested individuals to run a node. Built with the Cosmos SDK, Injective integrates several components, each contributing uniquely to its operations.

Key components

  • Injective Chain: The heart of Injective's operation lies in its custom-built Injective Chain, a layer-1 blockchain constructed with the Cosmos SDK. This forms the foundation, offering a robust infrastructure for creating and deploying various DeFi applications. Leveraging the Cosmos SDK, Injective achieves remarkable performance, with transaction speeds exceeding 10,000 transactions per second (TPS) and nearly instant transaction finality.

  • Injective exchange: Operating on the Injective Chain, the decentralized exchange (DEX) facilitates seamless trading of various cryptocurrencies, including spot, perpetual, futures, and options — all executed on-chain. The exchange features a fully decentralized and Miner Extractable Value (MEV)-resistant on-chain order book, providing transparency, efficiency, and protection against front-running in trading.

  • Interoperability framework: Injective employs a multifaceted approach to achieve interoperability. With the Cosmos SDK as a foundation, Injective can effectively interact with blockchain networks within Cosmos (ATOM) through the Inter-Blockchain Communication Protocol (IBC). Beyond the Cosmos ecosystem, Injective uses a decentralized cross-chain bridging infrastructure to connect with external blockchains, covering both Ethereum Virtual Machine (EVM) and non-EVM chains. Through the Injective bridge, Injective provides compatibility with a broader range of blockchains, including Ethereum (ETH), Solana (SOL), Klaytn (KLAY), and others. This interoperability isn't limited to assets alone. It encompasses applications and platforms that rely on smart contracts from different blockchain ecosystems.

  • Injective API nodes: Injective API nodes serve as the data layer for the network, offering real-time data indexing, transaction relay capabilities, and gas-free transactions. This means that anyone, from developers to users, can leverage this data to create user interfaces, conduct programmatic trading, and host DApps and analytics interfaces without the burden of gas fees.

  • CosmWasm: Injective integrates CosmWasm, a powerful smart contract layer based on the Cosmos SDK. This implementation goes beyond traditional smart contracts, allowing for automatic execution at every block, removing the need for external agents and enabling true decentralization in application development.

  • Electro Chains: Injective's adoption of Electro Chains further expands its reach. These chains facilitate the integration of Ethereum and Solana-based smart contracts into the Injective ecosystem. The introduction of Injective Ethereum Virtual Machine (inEVM) and Injective Solana Virtual Machine (inSVM) provides developers with seamless deployment options. The tools enable developers to bring their DApps to a wider audience within the Injective universe.

Who created Injective?

Injective was founded in 2018 by Eric Chen and Albert Chon, both prominent figures in the blockchain space. Chen, Injective's CEO, has a strong background in computer science and engineering, and champions making blockchain accessible and efficient in finance. Chon, the entity's CTO, brings financial and technological expertise, and envisions a financial future without limits.

Injective Labs, the parent company of Injective Protocol, which forms the core blockchain network and infrastructure, takes charge of the protocol's strategic direction, development, and support. This includes managing broader aspects such as partnerships, funding, and ecosystem growth.

Together, Injective's co-founders share a common goal: to break down barriers and democratize financial access through the Injective platform. Their combined efforts have fueled Injective's emergence as a groundbreaking blockchain, empowering developers and users to explore new horizons in DeFi.

Injective's native token: INJ

The platform's native token, INJ, serves multiple functions within the Injective blockchain, with diverse use cases extending beyond transactions.

Use cases

Besides being a medium of exchange, it plays a vital role in sustaining the platform's health and governance. INJ holders actively engage in building the future of Injective, using their voting power to influence decisions on upgrades, parameter adjustments, and governance matters.

Additionally, INJ enhances network security through staking, where validators stake their tokens to validate transactions and secure the network, earning rewards in return. INJ also provides a pathway to cost efficiency by allowing users to reduce transaction fees. Meanwhile, it unlocks various incentives within the Injective ecosystem, fostering a mutually beneficial relationship between token holders and the broader community.

Token supply and distribution

The initial supply of INJ consists of 100,000,000 tokens, strategically distributed to fuel the development and sustainability of the ecosystem. A significant portion, 36%, is allocated to ecosystem development, making sure of substantial funding for its ongoing growth. The team is granted 20%, aligning their interests with the platform's long-term success. The remaining tokens went to private sale (17%), community growth (10%), Binance Launchpad (9%), seed sale (6%), and advisors (2%), each playing a crucial role in shaping and enriching different facets of the Injective ecosystem.

Deflationary tokenomics

A distinctive feature of Injective is its token burn mechanism, where a significant portion of fees is directed towards a weekly on-chain buy-back-and-burn auction. Specifically, 60% of all fees collected, including those generated by exchange DApps, are burned weekly, contributing to the deflationary supply of the INJ token. Simultaneously, developers can earn 40% of the fees generated on the platform. This is an incentive mechanism designed to reward and motivate developers for their contributions to the ecosystem.

This cycle fosters a mutually beneficial relationship where user activity contributes to the token's scarcity, positively impacting its value. Meanwhile, developers are rewarded for their contributions, encouraging further development.

Ecosystem growth and support

With a thriving ecosystem that boasts more than 100 projects and a global community exceeding 350,000 members, Injective has become a driving force in the Web3 space. This flourishing network isn't only a testament to the platform's technical robustness but also to the enthusiasm and engagement of its diverse and expansive community.

Injective's growth is propelled by the support of Web3 innovators and esteemed backers. Key players such as Binance, Pantera Capital, Jump Crypto, and entrepreneur Mark Cuban have recognized Injective's transformative potential. Their involvement not only validates the project's vision but also infuses it with the resources and strategic guidance necessary for success.

Within Injective's bustling ecosystem, numerous projects are making waves. Notable names include Helix, Astroport, Talis, and myriad others, each contributing unique factors to the broader landscape.

The final word

As the world of Web3 finance evolves, Injective remains at the forefront, supporting advancements that empower users and developers. To many, the platform's commitment to decentralization, interoperability, and scalability position Injective as a trailblazer, and an entity that's well placed to play an important role in the future growth of the DeFi landscape.

This article may cover content on products that are not available in your region. It is provided for general informational purposes only, no responsibility or liability is accepted for any errors of fact or omission expressed herein. It represents the personal views of the author(s) and it does not represent the views of OKX. It is not intended to provide advice of any kind, including but not limited to: (i) investment advice or an investment recommendation; (ii) an offer or solicitation to buy, sell, or hold digital assets, or (iii) financial, accounting, legal, or tax advice. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk, can fluctuate greatly, and can even become worthless. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. OKX Web3 features, including OKX Web3 Wallet and OKX NFT Marketplace, are subject to separate terms of service at www.okx.com.
© 2023 OKX. This article may be reproduced or distributed in its entirety, or excerpts of 100 words or less of this article may be used, provided such use is non-commercial. Any reproduction or distribution of the entire article must also prominently state:"This article is © 2023 OKX and is used with permission." Permitted excerpts must cite to the name of the article and include attribution, for example "Article Name, [author name if applicable], © 2023 OKX." No derivative works or other uses of this article are permitted.
Related articles
View more
View more